Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Evaluation of Gut-Related Well-Being and Mood Effects of a Daily Nutritional Food Ingredient From the Co-Fermentation of Fungal Mycelium (Pleurotus Pulmonarius) and Microalgae (Chlorella Vulgaris)

Koralo GmbH · NCT07407777

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18+ · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Not applicable
Target enrollment
80
US sites recruiting
1
Study start
January 19, 2026
Record last updated
February 12, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The purpose of the study is to evaluate the gut-related well-being and mood effects of a food ingredient obtained from the co-fermentation of oyster mushroom mycelium (Pleurotus pulmonarius), microalgae (Chlorella vulgaris), and bamboo fibre in healthy adults (aged 18+) experiencing minor gastrointestinal discomfort during an intervention period of 30 days. The participants will be allocated into two unbalanced groups to determine relationships between the measurable outcomes and the dose levels at three different time points: start of the study (baseline), 15 days (middle), and 30 days (end-point), during which participants will be asked to complete GSRS and POMS-2-SF questionnaire

Being studied: Food ingredient of oyster mushroom mycelium (Pleurotus pulmonarius) and microalgae (Chlorella vulgaris)

Conditions: Gastrointestinal Discomfort; Digestive Well Being; Gut-related Symptoms

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

Adults aged 18 years or older

Generally healthy individuals

Experience minor, non-clinical gastrointestinal discomfort at least twice per week for ≥3 months

Willing to consume the study product once daily for 30 days

Able to dissolve and consume the powdered product in a beverage

Able to read, understand, and complete electronic questionnaires in English

Access to a smartphone or computer for study participation

Provide electronic informed consent

Exclusion Criteria

  • Diagnosed gastrointestinal disease (e.g., IBS, IBD, GERD requiring medication)

Use of medications affecting gastrointestinal function or mood within the past 30 days

Initiation of new gut-, immune-, or mood-related supplements within 15 days prior to study start

Known allergy or sensitivity to study product components

Pregnancy or breastfeeding

Major chronic medical condition that could interfere with study participation or data interpretation

Participation in another interventional clinical study within the past 30 days

Inability or unwillingness to comply with study procedures

Recruiting US locations

  • Alethios, Inc.

    San Francisco, CA 94109

    Site contact: Zoe Benham, B.S. · 9562771765 · zoe@alethios.com

Study contacts (from the official record)

  • Guido Albanese, PhD · +49 163 9144333 · guido@koralo-foods.com
  • Zoe Benham, B.S. · zoe@alethios.com
Evaluation of Gut-Related Well-Being and Mood Effects of a Daily… (NCT07407777) | Bored Studies